Evidence map›Paper›PMID 34947836›Full record

ArticleLife (Basel, Switzerland)2021

Predicting Three-Dimensional Dose Distribution of Prostate Volumetric Modulated Arc Therapy Using Deep Learning.

Patiparn Kummanee, Wares Chancharoen, Kanut Tangtisanon, Todsaporn Fuangrod

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Nested CNN architecture for three-dimensional dose distribution prediction in tomotherapy for prostate cancer.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Patiparn KummaneePrincess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok 10210, Thailand.
Wares ChancharoenPrincess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok 10210, Thailand.ORCID 0000-0002-5223-4867
Kanut TangtisanonDepartment of Computer Engineering, King Mongkut's Institute of Technology Ladkrabang, Bangkok 10520, Thailand.
Todsaporn FuangrodPrincess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok 10210, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVolumetric modulated arc therapy (VMAT) planning is a time-consuming process of radiation therapy. With a deep learning approach, 3D dose distribution can be predicted without the need for an actual dose calculation. This approach can accelerate the process by guiding and confirming the achievable dose distribution in order to reduce the replanning iterations while maintaining the plan quality.

methodsIn this study, three dose distribution predictive models of VMAT for prostate cancer were developed, evaluated, and compared. Each model was designed with a different input data structure to train and test the model: (1) patient CT alone (PCT alone), (2) patient CT and generalized organ structure (PCTGOS), and (3) patient CT and specific organ structure (PCTSOS). The generative adversarial network (GAN) model was used as a core learning algorithm. The models were trained slice-by-slice using 46 VMAT plans for prostate cancer, and then used to predict and evaluate the dose distribution from 8 independent plans.

resultsVMAT dose distribution was generated with a mean prediction time of approximately 3.5 s per patient, whereas the PCTSOS model was excluded due to a mean prediction time of approximately 17.5 s per patient. The highest average 3D gamma passing rate was 80.51 ± 5.94, while the lowest overall percentage difference of dose-volume histogram (DVH) parameters was 6.01 ± 5.44% for the prescription dose from the PCTGOS model. However, the PCTSOS model was the most reliable for the evaluation of multiple parameters.

conclusionsThis dose prediction model could accelerate the iterative optimization process for the planning of VMAT treatment by guiding the planner with the desired dose distribution.

Indexed as

deep learningdose distribution predictiongenerative adversarial networkprostate cancerVMAT

Identifiers

PMID34947836
PMCPMC8706736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.